Cargando…
Detecting Neuroimaging Biomarkers for Psychiatric Disorders: Sample Size Matters
In a recent review, it was suggested that much larger cohorts are needed to prove the diagnostic value of neuroimaging biomarkers in psychiatry. While within a sample, an increase of diagnostic accuracy of schizophrenia (SZ) with number of subjects (N) has been shown, the relationship between N and...
Autores principales: | Schnack, Hugo G., Kahn, René S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814515/ https://www.ncbi.nlm.nih.gov/pubmed/27064972 http://dx.doi.org/10.3389/fpsyt.2016.00050 |
Ejemplares similares
-
Revealing the impact of psychiatric comorbidities on treatment outcome in early psychosis using counterfactual model explanation
por: van Dee, Violet, et al.
Publicado: (2023) -
Editorial: Neuroimaging Biomarkers in Mood and Anxiety Disorders
por: Lai, Chien-Han, et al.
Publicado: (2021) -
Longitudinal Single Photon Emission Computed Tomography Neuroimaging as an Indication of Improvement in Psychiatric Disorders in a Community Psychiatric Practice
por: Thornton, John F., et al.
Publicado: (2022) -
Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
por: Li, Cheng-Ta, et al.
Publicado: (2019) -
Normative model detects abnormal functional connectivity in psychiatric disorders
por: Oliveira-Saraiva, Duarte, et al.
Publicado: (2023)